I think when the Ceplene deal is announced, we'll see a spike above 2 cents, maybe hit 3 cents if we're lucky for a day and then a quick pull back where we'll settle between 1-2 cents. It will all come down to how much they can get for Bert at this point. They need to get at least 10 million and maybe a little more than that for shareholders to get anything. UCI results should come anytime in the next 4 weeks. The trial is definitely over at this point, so its just however long to takes to compile the data. If we get positive results, it will be a huge boost to the stock. And make the valuation of Bert go up significantly as far as what someone will pay in cash today as opposed to future milestones. The offers they received had alot tied to future payments- I'm sure there was a big milestone payment based upon positive UCI results, so if we have those going into the deal, that's that much more that can be put into the present value.
Whats also interesting, is in the filing they say that maybe the sale could still contain some future payments. But the only way that would happen is if Immune stayed in business and emerged from BK.
